Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000469362 | SCV000563691 | likely benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000569336 | SCV000674936 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000569336 | SCV002527758 | benign | Hereditary cancer-predisposing syndrome | 2021-10-04 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478053 | SCV004220311 | likely benign | not provided | 2023-01-20 | criteria provided, single submitter | clinical testing |